価格表

在庫・価格 : 2024年05月03日 20時35分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-BCRP, Mouse-Mono(BXP-21) <Anti-Breast Cancer Resistance Protein>
データシート
GTX23380 GNTジーンテックス
GeneTex International Corporation
250 μl ¥98,000
(未発注)
追加

在庫・価格 : 2024年05月03日 20時35分 現在

Anti-BCRP, Mouse-Mono(BXP-21) <Anti-Breast Cancer Resistance Protein>

  • 商品コード:GTX23380
  • メーカー:GNT
  • 包装:250μl
  • 価格: ¥98,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Yonemori K et al. Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer. Cancer 2010 Jan;116(2):302-8
Yonemori K et al
2010/01/01
Application: IHC-P, Reactivity: Hu PubMed
2 Yamasaki T et al. Evaluation of the P-glycoprotein- and breast cancer resistance protein-mediated brain penetration of 11C-labeled topotecan using small-animal positron emission tomography. Nucl. Med. Biol. 2011 Jul;38(5):707-14
Yamasaki T et al
2011/01/01
Application: Western blot, Reactivity: Human PubMed
3 Kim DG et al. A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier. J. Clin. Invest. 2016 May;126(5):1717-33
Kim DG et al
2016/01/01
PubMed
4 Zhang YK et al. Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters. Sci Rep 2016 May;6:25694
Zhang YK et al
2016/01/01
PubMed
5 Trumpi K et al. ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer. J Cancer 2015;6(11):1079-86
Trumpi K et al
2015/01/01
PubMed
6 Zhang GN et al. Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib. Pharmacol. Res. 2017 May;119:89-98
Zhang GN et al
2017/01/01
PubMed
7 Zhang GN et al. Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In&#xA0;vitro and in&#xA0;vivo. Cancer Lett. 2018 Jun;424:19-29
Zhang GN et al
2018/01/01
Application: Western Blot (WB), Reactivity: Human PubMed
8 Zhang YK et al. Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer. Cancer Lett. 2019 Feb;442:104-112
Zhang YK et al
2019/01/01
Application: Western Blot PubMed
9 Cai CY et al. Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor. Biochem. Pharmacol. 2020 May;175:113848
Cai CY et al
2020/01/01
PubMed
  • No.: 1
  • 文献情報:
    Yonemori K et al. Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2/neu-positive breast cancer. Cancer 2010 Jan;116(2):302-8
    Yonemori K et al
    2010/01/01
  • 備考:
    Application: IHC-P, Reactivity: Hu
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yamasaki T et al. Evaluation of the P-glycoprotein- and breast cancer resistance protein-mediated brain penetration of 11C-labeled topotecan using small-animal positron emission tomography. Nucl. Med. Biol. 2011 Jul;38(5):707-14
    Yamasaki T et al
    2011/01/01
  • 備考:
    Application: Western blot, Reactivity: Human
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kim DG et al. A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier. J. Clin. Invest. 2016 May;126(5):1717-33
    Kim DG et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Zhang YK et al. Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters. Sci Rep 2016 May;6:25694
    Zhang YK et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Trumpi K et al. ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer. J Cancer 2015;6(11):1079-86
    Trumpi K et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Zhang GN et al. Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib. Pharmacol. Res. 2017 May;119:89-98
    Zhang GN et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Zhang GN et al. Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In&#xA0;vitro and in&#xA0;vivo. Cancer Lett. 2018 Jun;424:19-29
    Zhang GN et al
    2018/01/01
  • 備考:
    Application: Western Blot (WB), Reactivity: Human
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Zhang YK et al. Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer. Cancer Lett. 2019 Feb;442:104-112
    Zhang YK et al
    2019/01/01
  • 備考:
    Application: Western Blot
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Cai CY et al. Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor. Biochem. Pharmacol. 2020 May;175:113848
    Cai CY et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed